Last 12 months
Inside the activity.
0 purchase rows · 3 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 14, 2020 Filed Feb 19, 2020 20:37 UTC |
Jonaitis Mark S.SVP and GM, X-Ray Sources
|
Exercise / conversionRestricted Stock Units · Derivative | 1,147 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-20-000027 · wf-form4_158216262470727.xml · derivative · entry 6 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,293 Underlying: Common Stock · 1,147 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F4 · derivative.exercise_date: These Restricted Stock Units granted on February 15, 2018 vest 25% each year for four years beginning on February 15, 2019. Vested shares will be delivered to the reporting person upon vest date. F4 · derivative.expiration_date: These Restricted Stock Units granted on February 15, 2018 vest 25% each year for four years beginning on February 15, 2019. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 20:37 UTC |
Jonaitis Mark S.SVP and GM, X-Ray Sources
|
Exercise / conversionRestricted Stock Units · Derivative | 1,520 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-20-000027 · wf-form4_158216262470727.xml · derivative · entry 5 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,521 Underlying: Common Stock · 1,520 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: These Restricted Stock Units granted on February 16, 2017 vest 25% each year for four years beginning on February 15, 2018. Vested shares will be delivered to the reporting person upon vest date. F3 · derivative.expiration_date: These Restricted Stock Units granted on February 16, 2017 vest 25% each year for four years beginning on February 15, 2018. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 20:37 UTC |
Jonaitis Mark S.SVP and GM, X-Ray Sources
|
Tax withholdingCommon Stock | 1,958 | $25.89 | $50,692.62 |
DisclosureSEC source: 0001681622-20-000027 · wf-form4_158216262470727.xml · nonDerivative · entry 4 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,502 F2 · shares: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein. Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 20:37 UTC |
Jonaitis Mark S.SVP and GM, X-Ray Sources
|
Exercise / conversionCommon Stock | 1,354 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-20-000027 · wf-form4_158216262470727.xml · nonDerivative · entry 3 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,460 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 20:37 UTC |
Jonaitis Mark S.SVP and GM, X-Ray Sources
|
Exercise / conversionCommon Stock | 1,147 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-20-000027 · wf-form4_158216262470727.xml · nonDerivative · entry 2 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,106 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 20:37 UTC |
Jonaitis Mark S.SVP and GM, X-Ray Sources
|
Exercise / conversionCommon Stock | 1,520 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-20-000027 · wf-form4_158216262470727.xml · nonDerivative · entry 1 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,959 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 20:37 UTC |
VERHOEF CLARENCE RSVP & Chief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 2,149 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-20-000026 · wf-form4_158216260305466.xml · derivative · entry 7 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,447 Underlying: Common Stock · 2,149 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F6 · derivative.exercise_date: These Restricted Stock Units granted on February 15, 2019 vest 25% each year for four years beginning on February 15, 2020. Vested shares will be delivered to the reporting person upon vest date. F6 · derivative.expiration_date: These Restricted Stock Units granted on February 15, 2019 vest 25% each year for four years beginning on February 15, 2020. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 20:37 UTC |
VERHOEF CLARENCE RSVP & Chief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,820 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-20-000026 · wf-form4_158216260305466.xml · derivative · entry 6 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,640 Underlying: Common Stock · 1,820 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F5 · derivative.exercise_date: These Restricted Stock Units granted on February 15, 2018 vest 25% each year for four years beginning on February 15, 2019. Vested shares will be delivered to the reporting person upon vest date. F5 · derivative.expiration_date: These Restricted Stock Units granted on February 15, 2018 vest 25% each year for four years beginning on February 15, 2019. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 20:37 UTC |
VERHOEF CLARENCE RSVP & Chief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 2,413 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-20-000026 · wf-form4_158216260305466.xml · derivative · entry 5 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,414 Underlying: Common Stock · 2,413 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F4 · derivative.exercise_date: These Restricted Stock Units granted on February 16, 2017 vest 25% each year for four years beginning on February 15, 2018. Vested shares will be delivered to the reporting person upon vest date. F4 · derivative.expiration_date: These Restricted Stock Units granted on February 16, 2017 vest 25% each year for four years beginning on February 15, 2018. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 20:37 UTC |
VERHOEF CLARENCE RSVP & Chief Financial Officer
|
Tax withholdingCommon Stock | 2,008 | $25.89 | $51,987.12 |
DisclosureSEC source: 0001681622-20-000026 · wf-form4_158216260305466.xml · nonDerivative · entry 4 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,395 F3 · shares: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein. Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 20:37 UTC |
VERHOEF CLARENCE RSVP & Chief Financial Officer
|
Exercise / conversionCommon Stock | 2,149 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-20-000026 · wf-form4_158216260305466.xml · nonDerivative · entry 3 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,403 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 20:37 UTC |
VERHOEF CLARENCE RSVP & Chief Financial Officer
|
Exercise / conversionCommon Stock | 1,820 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-20-000026 · wf-form4_158216260305466.xml · nonDerivative · entry 2 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,254 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 20:37 UTC |
VERHOEF CLARENCE RSVP & Chief Financial Officer
|
Exercise / conversionCommon Stock | 2,413 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-20-000026 · wf-form4_158216260305466.xml · nonDerivative · entry 1 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,434 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F2 · balance_after: Amount of securities beneficially owned at end of reporting period reflect 70 shares purchased under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan. Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 20:36 UTC |
SANYAL SUNNYDirector · President and CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 8,374 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-20-000024 · wf-form4_158216256077601.xml · derivative · entry 7 SANYAL SUNNY · CIK 0001599398 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,122 Underlying: Common Stock · 8,374 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F6 · derivative.exercise_date: These Restricted Stock Units granted on February 15, 2019 vest 25% each year for four years beginning on February 15, 2020. Vested shares will be delivered to the reporting person upon vest date. F6 · derivative.expiration_date: These Restricted Stock Units granted on February 15, 2019 vest 25% each year for four years beginning on February 15, 2020. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 20:36 UTC |
SANYAL SUNNYDirector · President and CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 7,092 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-20-000024 · wf-form4_158216256077601.xml · derivative · entry 6 SANYAL SUNNY · CIK 0001599398 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,184 Underlying: Common Stock · 7,092 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F5 · derivative.exercise_date: These Restricted Stock Units granted on February 15, 2018 vest 25% each year for four years beginning on February 15, 2019. Vested shares will be delivered to the reporting person upon vest date. F5 · derivative.expiration_date: These Restricted Stock Units granted on February 15, 2018 vest 25% each year for four years beginning on February 15, 2019. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 20:36 UTC |
SANYAL SUNNYDirector · President and CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 9,363 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-20-000024 · wf-form4_158216256077601.xml · derivative · entry 5 SANYAL SUNNY · CIK 0001599398 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,363 Underlying: Common Stock · 9,363 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F4 · derivative.exercise_date: These Restricted Stock Units granted on February 16, 2017 vest 25% each year for four years beginning on February 15, 2018. Vested shares will be delivered to the reporting person upon vest date. F4 · derivative.expiration_date: These Restricted Stock Units granted on February 16, 2017 vest 25% each year for four years beginning on February 15, 2018. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 20:36 UTC |
SANYAL SUNNYDirector · President and CEO
|
Tax withholdingCommon Stock | 11,075 | $25.89 | $286,731.75 |
DisclosureSEC source: 0001681622-20-000024 · wf-form4_158216256077601.xml · nonDerivative · entry 4 SANYAL SUNNY · CIK 0001599398 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,145 F3 · shares: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein. Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 20:36 UTC |
SANYAL SUNNYDirector · President and CEO
|
Exercise / conversionCommon Stock | 8,374 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-20-000024 · wf-form4_158216256077601.xml · nonDerivative · entry 3 SANYAL SUNNY · CIK 0001599398 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,220 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 20:36 UTC |
SANYAL SUNNYDirector · President and CEO
|
Exercise / conversionCommon Stock | 7,092 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-20-000024 · wf-form4_158216256077601.xml · nonDerivative · entry 2 SANYAL SUNNY · CIK 0001599398 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,846 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 20:36 UTC |
SANYAL SUNNYDirector · President and CEO
|
Exercise / conversionCommon Stock | 9,363 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-20-000024 · wf-form4_158216256077601.xml · nonDerivative · entry 1 SANYAL SUNNY · CIK 0001599398 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,754 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F2 · balance_after: Amount of securities beneficially owned at end of reporting period reflect 992 shares purchased under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan. Read SEC document |
| February 14, 2020 Filed Feb 20, 2020 01:38 UTC |
Yankton Kevin BruceChief Accounting Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 954 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-20-000029 · wf-form4_158216266629549.xml · derivative · entry 7 Yankton Kevin Bruce · CIK 0001697197 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,865 Underlying: Common Stock · 954 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F5 · derivative.exercise_date: These Restricted Stock Units granted on February 15, 2019 vest 25% each year for four years beginning on February 15, 2020. Vested shares will be delivered to the reporting person upon vest date. F5 · derivative.expiration_date: These Restricted Stock Units granted on February 15, 2019 vest 25% each year for four years beginning on February 15, 2020. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| February 14, 2020 Filed Feb 20, 2020 01:38 UTC |
Yankton Kevin BruceChief Accounting Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 943 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-20-000029 · wf-form4_158216266629549.xml · derivative · entry 6 Yankton Kevin Bruce · CIK 0001697197 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,887 Underlying: Common Stock · 943 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F4 · derivative.exercise_date: These Restricted Stock Units granted on February 15, 2018 vest 25% each year for four years beginning on February 15, 2019. Vested shares will be delivered to the reporting person upon vest date. F4 · derivative.expiration_date: These Restricted Stock Units granted on February 15, 2018 vest 25% each year for four years beginning on February 15, 2019. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| February 14, 2020 Filed Feb 20, 2020 01:38 UTC |
Yankton Kevin BruceChief Accounting Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,341 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-20-000029 · wf-form4_158216266629549.xml · derivative · entry 5 Yankton Kevin Bruce · CIK 0001697197 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,341 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: These Restricted Stock Units granted on February 16, 2017 vest 33 1/3% each year for three years beginning on February 15, 2018. Vested shares will be delivered to the reporting person upon vest date. F3 · derivative.expiration_date: These Restricted Stock Units granted on February 16, 2017 vest 33 1/3% each year for three years beginning on February 15, 2018. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| February 14, 2020 Filed Feb 20, 2020 01:38 UTC |
Yankton Kevin BruceChief Accounting Officer
|
Tax withholdingCommon Stock | 1,609 | $25.89 | $41,657.01 |
DisclosureSEC source: 0001681622-20-000029 · wf-form4_158216266629549.xml · nonDerivative · entry 4 Yankton Kevin Bruce · CIK 0001697197 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,629 F2 · shares: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein. Read SEC document |
| February 14, 2020 Filed Feb 20, 2020 01:38 UTC |
Yankton Kevin BruceChief Accounting Officer
|
Exercise / conversionCommon Stock | 954 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-20-000029 · wf-form4_158216266629549.xml · nonDerivative · entry 3 Yankton Kevin Bruce · CIK 0001697197 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,238 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| February 14, 2020 Filed Feb 20, 2020 01:38 UTC |
Yankton Kevin BruceChief Accounting Officer
|
Exercise / conversionCommon Stock | 943 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-20-000029 · wf-form4_158216266629549.xml · nonDerivative · entry 2 Yankton Kevin Bruce · CIK 0001697197 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,284 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| February 14, 2020 Filed Feb 20, 2020 01:38 UTC |
Yankton Kevin BruceChief Accounting Officer
|
Exercise / conversionCommon Stock | 1,341 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-20-000029 · wf-form4_158216266629549.xml · nonDerivative · entry 1 Yankton Kevin Bruce · CIK 0001697197 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,341 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| February 13, 2020 Filed Feb 19, 2020 01:00 UTC |
Rosebrough Walter M JrDirector
|
GrantDeferred Stock Units · Derivative | 6,160 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-20-000012 · wf-form4_158207399222455.xml · derivative · entry 1 Rosebrough Walter M Jr · CIK 0001413087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,160 Underlying: Common Stock · 6,160 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · derivative.exercise_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the date of the first annual meeting following the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) February 15, 2023, (ii) a change in control or (iii) the reporting person's termination of service for any reason. F2 · derivative.expiration_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the date of the first annual meeting following the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) February 15, 2023, (ii) a change in control or (iii) the reporting person's termination of service for any reason. Read SEC document |
| February 13, 2020 Filed Feb 19, 2020 01:01 UTC |
TSINGOS CHRISTINE ADirector
|
GrantDeferred Stock Units · Derivative | 6,160 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-20-000015 · wf-form4_158207405349647.xml · derivative · entry 2 TSINGOS CHRISTINE A · CIK 0001278861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,160 Underlying: Common Stock · 6,160 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · derivative.exercise_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the date of the first annual meeting following the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) February 15, 2023, (ii) a change in control or (iii) the reporting person's termination of service for any reason. F2 · derivative.expiration_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the date of the first annual meeting following the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) February 15, 2023, (ii) a change in control or (iii) the reporting person's termination of service for any reason. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 20:01 UTC |
NAUMANN-ETIENNE RUEDIGERDirector
|
GrantDeferred Stock Units · Derivative | 8,471 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-20-000017 · wf-form4_158207409522912.xml · derivative · entry 2 NAUMANN-ETIENNE RUEDIGER · CIK 0001219636 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,471 Underlying: Common Stock · 8,471 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · derivative.exercise_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the date of the first annual meeting following the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) February 15, 2023, (ii) a change in control or (iii) the reporting person's termination of service for any reason. F2 · derivative.expiration_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the date of the first annual meeting following the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) February 15, 2023, (ii) a change in control or (iii) the reporting person's termination of service for any reason. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 20:00 UTC |
REINHARDT ERICH RDirector
|
GrantDeferred Stock Units · Derivative | 6,160 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-20-000013 · wf-form4_158207401308251.xml · derivative · entry 5 REINHARDT ERICH R · CIK 0001555958 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,160 Underlying: Common Stock · 6,160 shares Expires not disclosed F2 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F4 · derivative.exercise_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the date of the first annual meeting following the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) February 15, 2023, (ii) a change in control or (iii) the reporting person's termination of service for any reason. F4 · derivative.expiration_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the date of the first annual meeting following the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) February 15, 2023, (ii) a change in control or (iii) the reporting person's termination of service for any reason. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 20:01 UTC |
Kunkel Jay K.Director
|
GrantDeferred Stock Units · Derivative | 6,160 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-20-000016 · wf-form4_158207407445552.xml · derivative · entry 2 Kunkel Jay K. · CIK 0001592005 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,160 Underlying: Common Stock · 6,160 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · derivative.exercise_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the date of the first annual meeting following the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) February 15, 2023, (ii) a change in control or (iii) the reporting person's termination of service for any reason. F2 · derivative.expiration_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the date of the first annual meeting following the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) February 15, 2023, (ii) a change in control or (iii) the reporting person's termination of service for any reason. Read SEC document |
| February 13, 2020 Filed Feb 19, 2020 01:00 UTC |
Chertoff Jocelyn DDirector
|
GrantDeferred Stock Units · Derivative | 6,160 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-20-000014 · wf-form4_158207403410583.xml · derivative · entry 2 Chertoff Jocelyn D · CIK 0001701927 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,160 Underlying: Common Stock · 6,160 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · derivative.exercise_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the date of the first annual meeting following the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) February 15, 2023, (ii) a change in control or (iii) the reporting person's termination of service for any reason. F2 · derivative.expiration_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the date of the first annual meeting following the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) February 15, 2023, (ii) a change in control or (iii) the reporting person's termination of service for any reason. Read SEC document |
| November 01, 2019 Filed Nov 5, 2019 17:50 UTC |
Jonaitis Mark S.SVP and GM, X-Ray Sources
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 13,530 | $0.00 Strike: $22.84 | $0.00 |
DisclosureSEC source: 0001681622-19-000076 · wf-form4_157299420093544.xml · derivative · entry 3 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,530 shares Expires 2019-11-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options were granted in connection with the spin-off from Varian Medical Systems, Inc. and were immediately exercisable because they replaced Varian options that had previously vested. Read SEC document |
| November 01, 2019 Filed Nov 5, 2019 17:50 UTC |
Jonaitis Mark S.SVP and GM, X-Ray Sources
|
SaleCommon Stock | 13,530 | $31.02 | $419,700.60 |
DisclosureSEC source: 0001681622-19-000076 · wf-form4_157299420093544.xml · nonDerivative · entry 2 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,439 F2 · price: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on May 20, 2019. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.19 to $31.39. The reporting person undertakes to provide Varex Imaging Corporation, any security holder of Varex Imaging Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| November 01, 2019 Filed Nov 5, 2019 17:50 UTC |
Jonaitis Mark S.SVP and GM, X-Ray Sources
|
Exercise / conversionCommon Stock | 13,530 | $22.84 | $309,025.20 |
DisclosureSEC source: 0001681622-19-000076 · wf-form4_157299420093544.xml · nonDerivative · entry 1 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,969 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 939 shares purchased under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan. Read SEC document |
| October 16, 2019 Filed Oct 17, 2019 17:43 UTC |
VERHOEF CLARENCE RSVP & Chief Financial Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 21,047 | $0.00 Strike: $22.84 | $0.00 |
DisclosureSEC source: 0001681622-19-000074 · wf-form4_157134858767853.xml · derivative · entry 3 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,047 shares Expires 2019-11-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options were granted in connection with the spin-off from Varian Medical Systems, Inc. and were immediately exercisable because they replaced Varian options that had previously vested. Read SEC document |
| October 16, 2019 Filed Oct 17, 2019 17:43 UTC |
VERHOEF CLARENCE RSVP & Chief Financial Officer
|
SaleCommon Stock | 21,047 | $28.94 | $609,100.18 |
DisclosureSEC source: 0001681622-19-000074 · wf-form4_157134858767853.xml · nonDerivative · entry 2 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,951 F2 · price: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on May 28, 2019. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.62 to $29.36. The reporting person undertakes to provide Varex Imaging Corporation, any security holder of Varex Imaging Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| October 16, 2019 Filed Oct 17, 2019 17:43 UTC |
VERHOEF CLARENCE RSVP & Chief Financial Officer
|
Exercise / conversionCommon Stock | 21,047 | $22.84 | $480,713.48 |
DisclosureSEC source: 0001681622-19-000074 · wf-form4_157134858767853.xml · nonDerivative · entry 1 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,998 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 901 shares purchased under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan. Read SEC document |
| July 15, 2019 Filed Jul 16, 2019 21:46 UTC |
Yankton Kevin BruceChief Accounting Officer
|
SaleCommon Stock | 1,149 | $31.00 | $35,619.00 |
DisclosureSEC source: 0001681622-19-000061 · wf-form4_156331357622470.xml · nonDerivative · entry 1 Yankton Kevin Bruce · CIK 0001697197 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on June 5, 2019. Read SEC document |
| July 05, 2019 Filed Jul 8, 2019 21:21 UTC |
Yankton Kevin BruceChief Accounting Officer
|
SaleCommon Stock | 268 | $30.56 | $8,190.08 |
DisclosureSEC source: 0001681622-19-000057 · wf-form4_156262088714955.xml · nonDerivative · entry 1 Yankton Kevin Bruce · CIK 0001697197 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,149 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on June 5, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.35 to $30.85. The reporting person undertakes to provide Varex Imaging Corporation, any security holder of Varex Imaging Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F3 · balance_after: Includes 268 shares acquired under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan. Read SEC document |
| June 26, 2019 Filed Jun 27, 2019 19:22 UTC |
Honeysett Kimberley E.SVP and General Counsel
|
SaleCommon Stock | 916 | $30.00 | $27,480.00 |
DisclosureSEC source: 0001681622-19-000055 · wf-form4_156167772384960.xml · nonDerivative · entry 1 Honeysett Kimberley E. · CIK 0001695094 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,039 F1 · price: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on May 15, 2019. F2 · balance_after: Includes 78 shares acquired under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan. Read SEC document |
| May 17, 2019 Filed May 17, 2019 17:20 UTC |
Giambattista Brian WSVP and GM, X-ray Detectors
|
SaleCommon Stock | 572 | $28.65 | $16,387.80 |
DisclosureSEC source: 0001681622-19-000050 · wf-form4_155812800371361.xml · nonDerivative · entry 3 Giambattista Brian W · CIK 0001705559 · SVP and GM, X-ray Detectors 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F3 · price: The sales reported in this Form 4 were effected pursuant to a 10b5-1 plan adopted by the reporting person on May 31, 2018. These shares were sold at prices ranging from $28.40 to $28.88 Read SEC document |
| May 15, 2019 Filed May 17, 2019 17:20 UTC |
Giambattista Brian WSVP and GM, X-ray Detectors
|
Exercise / conversionRestricted Stock Units · Derivative | 863 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-19-000050 · wf-form4_155812800371361.xml · derivative · entry 4 Giambattista Brian W · CIK 0001705559 · SVP and GM, X-ray Detectors 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,725 Underlying: Common Stock · 863 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F4 · derivative.exercise_date: The Restricted Stock Units granted on May 25, 2017 vest 25% each year for four years. The remaining Restricted Stock Units associated with this grant will vest on May 15, 2020 and May 15, 2021. F4 · derivative.expiration_date: The Restricted Stock Units granted on May 25, 2017 vest 25% each year for four years. The remaining Restricted Stock Units associated with this grant will vest on May 15, 2020 and May 15, 2021. Read SEC document |
| May 15, 2019 Filed May 17, 2019 17:20 UTC |
Giambattista Brian WSVP and GM, X-ray Detectors
|
Tax withholdingCommon Stock | 291 | $29.16 | $8,485.56 |
DisclosureSEC source: 0001681622-19-000050 · wf-form4_155812800371361.xml · nonDerivative · entry 2 Giambattista Brian W · CIK 0001705559 · SVP and GM, X-ray Detectors 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 572 F2 · shares: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein. Read SEC document |
| May 15, 2019 Filed May 17, 2019 17:20 UTC |
Giambattista Brian WSVP and GM, X-ray Detectors
|
Exercise / conversionCommon Stock | 863 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-19-000050 · wf-form4_155812800371361.xml · nonDerivative · entry 1 Giambattista Brian W · CIK 0001705559 · SVP and GM, X-ray Detectors 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 863 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| February 19, 2019 Filed Feb 20, 2019 19:57 UTC |
Giambattista Brian WSVP and GM, X-ray Detectors
|
SaleCommon Stock | 710 | $31.53 | $22,386.30 |
DisclosureSEC source: 0001681622-19-000037 · wf-form4_155071065812862.xml · nonDerivative · entry 3 Giambattista Brian W · CIK 0001705559 · SVP and GM, X-ray Detectors 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F3 · price: The sales reported in this Form 4 were effected pursuant to a 10b5-1 plan adopted by the reporting person on May 31, 2018. These shares were sold at prices ranging from $31.48 to $31.69 Read SEC document |
| February 15, 2019 Filed Feb 20, 2019 19:57 UTC |
Giambattista Brian WSVP and GM, X-ray Detectors
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 17,516 | $0.00 Strike: $31.42 | $0.00 |
DisclosureSEC source: 0001681622-19-000037 · wf-form4_155071065812862.xml · derivative · entry 6 Giambattista Brian W · CIK 0001705559 · SVP and GM, X-ray Detectors 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,516 Underlying: Common Stock · 17,516 shares Expires 2026-02-15 F6 · derivative.exercise_date: This Non-Qualified Stock Option is subject to a four-year vesting schedule. 25% of the total number of options vests one year from grant date, and the remaining options vests monthly thereafter on a pro rata basis. Read SEC document |
| February 15, 2019 Filed Feb 20, 2019 19:57 UTC |
Giambattista Brian WSVP and GM, X-ray Detectors
|
GrantRestricted Stock Units · Derivative | 5,680 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-19-000037 · wf-form4_155071065812862.xml · derivative · entry 5 Giambattista Brian W · CIK 0001705559 · SVP and GM, X-ray Detectors 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,680 Underlying: Common Stock · 5,680 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F5 · derivative.exercise_date: The Restricted Stock Units granted on February 15, 2019 vest 25% each year for four years beginning on February 15, 2020. Vested shares will be delivered to the reporting person upon vest date. F5 · derivative.expiration_date: The Restricted Stock Units granted on February 15, 2019 vest 25% each year for four years beginning on February 15, 2020. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| February 15, 2019 Filed Feb 20, 2019 19:57 UTC |
Giambattista Brian WSVP and GM, X-ray Detectors
|
Exercise / conversionRestricted Stock Units · Derivative | 1,202 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-19-000037 · wf-form4_155071065812862.xml · derivative · entry 4 Giambattista Brian W · CIK 0001705559 · SVP and GM, X-ray Detectors 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,609 Underlying: Common Stock · 1,202 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F4 · derivative.exercise_date: The Restricted Stock Units granted on February 15, 2018 vest 25% each year for four years beginning on February 15, 2019. Vested shares will be delivered to the reporting person upon vest date. F4 · derivative.expiration_date: The Restricted Stock Units granted on February 15, 2018 vest 25% each year for four years beginning on February 15, 2019. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.